Skip to main content

Table 7 Systemic vascular resistance index (dyn.s.cm−5)

From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

 

Terlipressin group (n = 50)

Placebo group (n = 50)

P value

Baseline

2573.49 ± 829.26

2319.10 ± 762.35

0.1135

0 min

2222.59 ± 1071.89

1134.29 ± 964.23

< 0.0001*

10 min

2324.29 ± 832.43

1437.53 ± 850.34

< 0.0001*

20 min

2406.47 ± 728.20

1548.14 ± 730.20

< 0.0001*

30 min

2429.03 ± 843.53

1628.11 ± 773.68

< 0.0001*

40 min

2438.24 ± 794.70

1630.09 ± 662.42

< 0.0001*

50 min

2406.25 ± 820.91

1625.31 ± 746.30

< 0.0001*

60 min

2438.09 ± 735.13

1575.05 ± 753.54

< 0.0001*

  1. Baseline reading before skin incision
  2. Minutes after weaning from cardiopulmonary bypass
  3. Mean ± SD
  4. *P value is significant when P < 0.05